ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

GWENDOLYN GRADDY M.D.

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,207Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 103

$122K Total Retail Price of All Prescriptions

Rank: 71 out of 103

277 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 277 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 277 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

0% of this provider’s 7,962 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$13 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
ASPIRIN EC 338 313 1 80
LISINOPRIL 324 275 2 2
HYDROCODONE-ACETAMINOPHEN 301 247 S3 3 3
AMLODIPINE BESYLATE 295 247 4 5
METOPROLOL SUCCINATE 285 267 5 17
FUROSEMIDE 232 202 6 6
DOK 218 188 7 151
PRAVASTATIN SODIUM 217 208 8 27
CERTAVITE SENIOR-ANTIOXIDANT 214 202 10 9 152
OYST-CAL-D 500 193 193 10 10 163
SIMVASTATIN 188 152 11 1
MAPAP 183 176 12 125
SENNA LAX 175 172 10 13 175
METOPROLOL TARTRATE 163 149 14 8
LEVOTHYROXINE SODIUM 160 158 15 4
GALANTAMINE HBR 144 144 16 88
NAMENDA 139 125 17 16
HYDRALAZINE HCL 130 84 18 34
SERTRALINE HCL 118 116 19 18
GABAPENTIN 118 99 19 13
MELATONIN 117 108 10 21 157
CITALOPRAM HBR 115 97 22 10
LANTUS 114 73 23 29
WARFARIN SODIUM 114 96 23 9
RANITIDINE HCL 112 105 25 31
OMEPRAZOLE 107 98 26 7
ISOSORBIDE MONONITRATE ER 107 99 26 26
ALBUTEROL SULFATE 96 74 28 76
LEVETIRACETAM 95 61 29 57
IPRATROPIUM BROMIDE 93 65 30 99
LOSARTAN POTASSIUM 90 86 31 23
POTASSIUM CHLORIDE 77 74 32 12
LACTULOSE 75 75 33 65
NIFEDIPINE ER 67 67 34 101
DONEPEZIL HCL 64 64 35 11
GLIPIZIDE XL 64 44 35 143
DIGOXIN 60 45 37 49
MIRTAZAPINE 60 59 37 24
ATENOLOL 59 59 39 19
CARVEDILOL 56 42 40 22
DIVALPROEX SODIUM 55 55 41 45
NOVOLOG 53 41 42 68
PREDNISONE 51 44 43 38
HYDROCHLOROTHIAZIDE 50 50 44 15
PANTOPRAZOLE SODIUM 50 41 44 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.